InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+3.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Yilmaz Mahshid, Chief Financial Officer. Director active across 1 company, notably Egetis Therapeutics AB (publ). In total, 2 filings have been logged. History available since 26 November 2025. The latest transaction was filed on 13 May 2026 (Sale). Regulator: FIN-FSA. The full history is openly available.
Declarations2 total
●
153,631 shares@ SEK 6.500.0043% mcap81.3% of flowAktieFI:A003Y582-1
●
60,000 shares@ €0.35090.0010% mcap18.7% of flowAktieFI:A003U276-2
Ideal exit: 23 Aug 2026 (T+270)
2 of 2 declarations
About Yilmaz Mahshid
Yilmaz Mahshid is the Chief Financial Officer of Egetis Therapeutics AB (publ). In this role, he is responsible for the financial management of the company, including budgeting and financial analysis. His expertise is essential to ensure the financial health of the organization.
